Viewing Study NCT04194359


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2025-12-25 @ 1:27 PM
Study NCT ID: NCT04194359
Status: UNKNOWN
Last Update Posted: 2023-03-17
First Post: 2019-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module